eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Bieżący numer Archiwum O czasopiśmie Suplementy Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac
NOWOŚĆ
Portal dla reumatologów!
www.ereumatologia.pl
SCImago Journal & Country Rank



 
1/2010
vol. 48
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł przeglądowy

Zastosowanie radiosynowektomii w leczeniu chorób reumatycznych

Magdalena Matryba, Małgorzata Wisłowska

Reumatologia 2010; 48, 1:54-61
Data publikacji online: 2010/04/09
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Radiosynowektomia to metoda miejscowego leczenia przewlekłych stanów zapalnych stawów, wykorzystująca zjawisko odbudowy błony maziowej pod wpływem promieniowania β, emitowanego przez radiofarmaceutyk podany dostawowo. Stanowi ona alternatywę dla chirurgicznej synowektomii, jest stosowana w przypadku nieskuteczności standardowych form terapii oraz dostawowych iniekcji glikokortykosteroidów. W pracy przedstawiono jej miejsce w leczeniu wybranych chorób reumatycznych oparte na dotychczasowych doświadczeniach klinicznych.

Radiosynovectomy is used to local treatment of chronic arthritis and it leads to renovation of synovium owing to beta radiation emitted by intraarticular injected radionuclide. It is alternative method to surgical synovectomy, used in case of inefficiency of standard therapy and steroid intraarticular injection. In this article we present using of radiosynoviorthesis in treatment of some rheumatoid disease based on clinical experiences.
słowa kluczowe:

radiosynowektomia, radioznaczniki, leczenie chorób reumatycznych

referencje:
Pirich C, Schwameis E, Bernecker P, et al. Influence of radiation synovectomy on articular cartilage, synovial thickness and enhancement as evidenced by MRI in patients with chronic synovitis. J Nucl Med 1999; 40: 1277-1284.  
Zwolak R. Radiosynowiorteza w codziennej praktyce. Przegl Reum 2008; 3-4: 1-2.  
Klett R, Lange U, Haas H, et al. Radiosynoviorthesis of medium-sized joints with rhenium-186-sulphide colloid: a review of the literature. Rheumatology (Oxford) 2007; 46: 1531-1537.  
Miszczyk L, Wozniak G, Jochymek B, et al. Effectiveness evaluation of knee joint 90Y radiosynovectomy. Przegl Lek 2007; 64: 450-453.  
Chattopadhyay S, Vimalnath KV, Saha S, et al. Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, 111Ag-labelled hydroxyapatite (HA) particles. Appl Radiat Isot 2008; 66: 334-339.  
Clunie G, Fischer M. EANM procedure guidelines for radiosynovectomy. Eur J Nucl Med 2003; 30: BP12–BP16.  
Ponsard B, Srivastava SC, Mausner LF, et al. Production of Sn-117m in the BR2 high-flux reactor. Appl Radiat Isot 2009; 67: 1158-1161.  
Lambert B, de Klerk JM. Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapy. Nucl Med Commun 2006; 27: 223-229.  
O’Duffy EK, Clunie GP, Lui D, et al. Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis. Ann Rheum Dis 1999; 58: 554-558. 
Schneider P, Farahati J, Reiners C. Radiosynovectomy in rheumatology, orthopedics, and hemophilia. J Nucl Med 2005; 46 Suppl 1: 48S-54S. 
Peters W, Lee P. Radiation necrosis overlying the ankle joint after injection with yttrium-90. Ann Plast Surg 1994; 32: 542-543. 
Mäkelä OT, Lammi MJ, Uusitalo H, et al. Analysis of lapine cartilage matrix after radiosynovectomy with holmium-166 ferric hydroxide macroaggregate. Ann Rheum Dis 2003; 62: 43-49. 
Mäkelä OT, Lammi MJ, Uusitalo H, et al. Effect of radiosynovectomy with holmium-166 ferric hydroxide macroaggregate on adult equine cartilage. J Rheumatol 2004; 31: 321-328. 
Gratz S, Göbel D, Behr TM, et al. Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis. J Rheumatol 1999; 26: 1242-1249. 
Manil L, Voisin P, Aubert B. Physical and biological dosimetry in patients undergoing radiosynoviorthesis with Erbium-169 and Rhenium-186. Nucl Med Commun 2001; 22: 405-416. 
van der Zant FM, Jahangier ZN, Moolenburgh JD, et al. Radiation synovectomy of the ankle with 75 MBq colloidal 186Rhenium-sulfide: Effect, leakage, and radiation considerations. J Rheumatol 2004; 31: 896-901. 
Grmek M, Milcinski M, Fettich J, et al. Assessment of radiation doses at haemophiliacs treated with radiosynoviorthesis with 186Re colloid. Eur J Nucl Med Mol Imaging 2006; 33 (Suppl. 2): S373. 
Badiavas K, Chatzopoulos D, Markou P. Radiation doses from patients undergoing yttrium-90 silicate knee radiosynovectomy. Hell J Nucl Med 2006; 9: 65-68. 
Markou P. Can hand radiation absorbed dose from radiosynomicronvectomy be high? Hell J Nucl Med 2006; 9: 191-194. 
Liepe K, Andreeff M, Wunderlich G, et al. Radiation protection in radiosynovectomy of the knee. Health Phys 2005; 89: 151-154. 
Turkmen C, Ozturk S, Unal SN, et al. The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid. Cancer Biother Radiopharm 2007; 22: 393-399. 
Fernandez-Palazzi F, Caviglia H. On the safety of synoviorthesis in haemophilia. Haemophilia 2001; 7 (Suppl. 2): 50-53. 
Vuorela J, Sokka T, Pukkala E, et al. Does yttrium radiosynovectomy increase the risk of cancer in patients with rheumatoid arthritis? Ann Rheum Dis 2003; 62: 251-253. 
van der Zant FM, Boer RO, Moolenburgh JD, et al. Radia- tion synovectomy with (90)Yttrium, (186)Rhenium and (169)Erbium: a systematic literature review with meta-analyses. Clin Exp Rheumatol 2009; 27: 130-139. 
Rampon S, Bussiere JZ, Prim P, et al. Synoviorthese par les radioisotopes. Rhumatologie 1976; 6: 123-135. 
Farahati J, Schulz G, Wendler J. Multivariate analysis of factors influencing the effect of radiosynovectomy. Nuklearmedizin 2002; 41: 114-119. 
Kresnik E, Mikosch P, Gallowitsch HJ, et al. Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints. Nucl Med Commun 2002; 23: 683-688. 
Rozeboom S, Dörr U, Bihl H. Radiosynovectomy for the treatment of rheumatoid arthritis of the elbow joint. Nuklearmedizin 2001; 40: 91-97. 
Tebib JG, Manil LM, Mödder G, et al. Better results with rhenium-186 radiosynoviorthesis than with cortivazol in rheumatoid arthritis (RA): a two-year follow-up randomized controlled multicentre study. Clin Exp Rheumatol 2004; 22: 609-616. 
Göbel D, Gratz S, von Rothkirch T, et al. Chronic polyarthritis and radiosynoviorthesis: a prospective, controlled study of injection therapy with erbium 169 and rhenium 186. Z Rheumatol 1997; 56: 207-213. 
Deutsch E, Brodack JW, Deutsch KF. Radiation synovectomy revisited. Eur J Nucl Med 1993; 20: 1113-1127. 
Troise Rioda W, Nervetti A, Mgolotii G, Adorni G. Knee radiosynovectomy with Y90 in patients with rheumatoid arthritis: our experiences. Reumatismo 2008; 60: 206-211. 
Kröger S, Sawula JA, Klutmann S, et al. Efficacy of radiation synovectomy in degenerative inflammatory and chronic inflammatory joint diseases. Nuklearmedizin 1999; 38: 279-284. 
Kampen WU, Brenner W, Kroeger S, et al. Long-term results of radiation synovectomy: a clinical follow-up study. Nucl Med Commun 2001; 22: 239-246. 
Clunie G, Ell PJ. A survey of radiation synovectomy in Europe, 1991–1993. Eur J Nucl Med 1995; 22: 970-976. 
Farahati J, Schulz G, Wendler J, et al. Multivariate analysis of factors influencing the effect of radiosynovectomy. Nuklearmedizin 2002; 41: 114-119. 
Rau H, Lohmann K, Franke C. Multicenter study of radiosynoviorthesis: clinical outcome in osteoarthritis and other disorders with concomitant synovitis in comparison with rheumatoid arthritis. Nuklearmedizin 2004; 43: 57-62. 
Fernandez-Pallazi F, de Bosch NB, de Vargas AF. Radioactive synovectomy in haemophilic haemarthrosis. Follow-up of fifty cases. Scand J Haematol 1984; 33: 291-300. 
Siegel HJ, Luck JV Jr, Siegel ME, et al. Phosphate-32 colloid radiosynovectomy in hemophilia: outcome of 125 procedures. Clin Orthop Relat Res 2001; 392: 409-417. 
Molho P, Verrier P, Stieltjes N. A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis. Haemophilia 1999; 5: 115-123. 
Grmek M, Milcinski M, Fettich J, et al. Radiosynoviorthesis for treatment of hemophilic hemarthrosis – Slovenian experience. Cancer Biother Radio 2005; 20: 338-343. 
Türkmen C, Zülflkar B, Taºer O, et al. Radiosynovectomy in hemophilic synovitis: correlation of therapeutic response and blood-pool changes. Cancer Biother Radiopharm 2005; 20: 363-370. 
van Kasteren ME, Nováková IR, Boerbooms AM, et al. Long term follow up of radiosynovectomy with yttrium-90 silicate in haemophilic haemarthrosis. Ann Rheum Dis 1993; 52: 548-550. 
Nassar WA, Bassiony AA, Elghazaly HA. Treatment of diffuse pigmented villonodular synovitis of the knee with combined surgical and radiosynovectomy. HSS J 2009; 5: 19-23. 
Kat S, Kutz R, Elbracht T, et al. Radiosynovectomy in pigmented villonodular synovitis. Nuklearmedizin 2000; 39: 209-213. 
Cayla J, Huchet B, Rondier J, et al. Hemarthrosis of articular chondrocalcinosis. A propos of 28 cases. Importance of treatment by isotopic synoviorthesis. Rev Rhum Mal Osteoartic 1982; 49: 281-285. 
Erselcan T, Bulut O, Bulut S, et al. Lipoma arborescens; successfully treated by yttrium-90 radiosynovectomy. Ann Nucl Med 2003; 17: 593-596.
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe